Chemoprevention Uptake among Women with Atypical Hyperplasia and Lobular and Ductal Carcinoma In Situ.

about

Early participant-reported symptoms as predictors of adherence to anastrozole in the International Breast Cancer Intervention Studies II.

P2860

Q48558036-23CC7C2C-EFD0-4D44-9881-B0629D231759

P2860

Chemoprevention Uptake among Women with Atypical Hyperplasia and Lobular and Ductal Carcinoma In Situ.

Item

http://www.wikidata.org/entity/Q38727084

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Chemoprevention Uptake among W ...... and Ductal Carcinoma In Situ.

@en

type

Item

label

Chemoprevention Uptake among W ...... and Ductal Carcinoma In Situ.

@en

prefLabel

Chemoprevention Uptake among W ...... and Ductal Carcinoma In Situ.

@en

P1476

Chemoprevention Uptake among W ...... and Ductal Carcinoma In Situ.

@en

P2093

Alejandro Vanegas

http://www.w3.org/2001/XMLSchema#string

Austin M Coe

http://www.w3.org/2001/XMLSchema#string

Katherine D Crew

http://www.w3.org/2001/XMLSchema#string

Meghna S Trivedi

http://www.w3.org/2001/XMLSchema#string

Rita Kukafka

http://www.w3.org/2001/XMLSchema#string

P2860

Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis

The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis.

Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women

Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data.

Willingness to use tamoxifen to prevent breast cancer among diverse women.

General performance on a numeracy scale among highly educated samples.

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer

P304

434-441

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1940-6207.CAPR-17-0100

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28611039

http://www.w3.org/2001/XMLSchema#string

P932

5540777

http://www.w3.org/2001/XMLSchema#string

Chemoprevention Uptake among Women with Atypical Hyperplasia and Lobular and Ductal Carcinoma In Situ.

about

P2860

P2860

Chemoprevention Uptake among Women with Atypical Hyperplasia and Lobular and Ductal Carcinoma In Situ.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932